AS1842856
Based on 92 publication(s) in Google Scholar
AS1842856, a specific Foxo1 inhibitor (IC50=30 nM), potently suppresses autophagy. AS1842856 reduces Foxo1 activity and, to a lesser extent, inhibits Foxo1 protein expression by simply binding to Foxo1.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.88%
- No. CAS: 836620-48-5
- Fòrmula: C18H22FN3O3
- Peso molecular:347.38
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) AS1842856
More- Cell. 2024 Feb 1;187(3):624-641.e23. [Abstract]
- Cell Res. 2025 Aug 29. [Abstract]
- Nat Cell Biol. 2025 Aug;27(8):1357-1366. [Abstract]
- Cancer Res. 2024 Sep 16;84(18):2985-3003. [Abstract]
- Theranostics. 2021 Jul 25;11(18):8624-8639. [Abstract]
- J Adv Res. 2025 Aug:74:493-511. [Abstract]
- Exp Mol Med. 2021 Sep;53(9):1307-1318. [Abstract]
- Mol Ther. 2026 Jun 2:S1525-0016(26)00470-3. [Abstract]
- Redox Biol. 2022 Jun;52:102311. [Abstract]
- Cell Rep Med. 2025 Dec 16;6(12):102513. [Abstract]
- Cell Rep Med. 2025 Sep 25:102371. [Abstract]
- J Exp Med. 2023 Oct 2;220(10):e20221653. [Abstract]
- Cell Mol Biol Lett. 2025 Mar 31;30(1):38. [Abstract]
- Mol Biomed. 2025 Oct 2;6(1):75. [Abstract]
- Cell Death Dis. 2023 Aug 8;14(8):508. [Abstract]
- Cell Death Dis. 2019 May; 10(5): 329. [Abstract]
- Sci China Life Sci. 2022 Dec;65(12):2505-2516. [Abstract]
- Proc Natl Acad Sci U S A. 2021 Nov 16;118(46):e2105950118. [Abstract]
- Acta Pharmacol Sin. 2024 Apr;45(4):714-727. [Abstract]
- Phytomedicine. 2025 Jun 8:144:156958. [Abstract]
- Apoptosis. 2022 Jun;27(5-6):329-341. [Abstract]
- J Orthop Translat. 2024 Sep 17:49:246-263. [Abstract]
- Redox Rep. 2025 Dec;30(1):2565033. [Abstract]
- Cell Mol Gastroenterol Hepatol. 2024 Dec 30:101454. [Abstract]
- Chin Med J (Engl). 2025 May 20;138(10):1213-1224. [Abstract]
- Stem Cell Res Ther. 2024 Aug 15;15(1):261. [Abstract]
- Aging Cell. 2024 Sep 17:e14336. [Abstract]
- Aging Cell. 2024 Mar;23(3):e14072. [Abstract]
- Cell Death Discov. 2025 Nov 7;11(1):509. [Abstract]
- Cell Rep. 2025 Sep 29;44(10):116361. [Abstract]
- Cell Rep. 2021 Apr 6;35(1):108935. [Abstract]
- Antioxidants (Basel). 2025 Mar 18;14(3):352. [Abstract]
- Mol Metab. 2021 Jul:49:101187. [Abstract]
- J Agric Food Chem. 2025 Jul 2;73(26):16557-16572. [Abstract]
- Diabetes Obes Metab. 2024 Feb;26(2):732-744. [Abstract]
- Cell Prolif. 2026 Apr 22:e70214. [Abstract]
- Biochem Pharmacol. 2024 Sep 3:116517. [Abstract]
- Food Funct. 2021 Sep 20;12(18):8800-8811. [Abstract]
- Drug Des Devel Ther. 2025 Mar 5:19:1543-1560. [Abstract]
- CNS Neurosci Ther. 2026 Apr;32(4):e70910. [Abstract]
- CNS Neurosci Ther. 2025 Apr;31(4):e70379. [Abstract]
- Immunology. 2023 Mar;168(3):511-525. [Abstract]
- PLoS Pathog. 2025 Apr 1;21(4):e1012524. [Abstract]
- PLoS Pathog. 2023 Aug 18;19(8):e1011581. [Abstract]
- Int J Mol Sci. 2022 Jan 28;23(3):1513. [Abstract]
- Int J Mol Sci. 2021 Feb 2;22(3):1478. [Abstract]
- J Nutr Biochem. 2020 Jun;80:108380. [Abstract]
- Int Immunopharmacol. 2025 Dec 19:170:116049. [Abstract]
- Int Immunopharmacol. 2024 Dec 28:146:113932. [Abstract]
- Biosci Rep. 2019 May 10;39(5):BSR20190112. [Abstract]
- Toxicology. 2021 Feb 15:449:152664. [Abstract]
- Front Cell Dev Biol. 2021 Aug 26;9:666422. [Abstract]
- J Cell Mol Med. 2025 Nov;29(21):e70849. [Abstract]
- Mol Nutr Food Res. 2024 Jun 7:e2300912. [Abstract]
- FASEB J. 2023 Feb;37(2):e22744. [Abstract]
- FASEB J. 2022 May;36(5):e22316. [Abstract]
- FASEB J. 2020 Oct;34(10):13762-13775. [Abstract]
- FEBS J. 2020 Jan;287(1):94-107. [Abstract]
- iScience. 2023 Jul 11;26(8):107293. [Abstract]
- J Integr Med. 2021 Nov;19(6):545-554. [Abstract]
- Sci Rep. 2025 Aug 6;15(1):28800. [Abstract]
- J Biol Chem. 2024 Apr;300(4):107209. [Abstract]
- J Biol Chem. 2021 Jul;297(1):100846. [Abstract]
- J Biol Chem. 2020 Mar 27;295(13):4265-4276. [Abstract]
- Int Dent J. 2026 Jun 5;76(4):109664. [Abstract]
- ACS Pharmacol Transl Sci. 2024 Apr 29;7(5):1237-1251. [Abstract]
- Mol Cell Biochem. 2023 Jul;478(7):1561-1571. [Abstract]
- Eur J Med Res. 2026 Jan 5;31(1):202. [Abstract]
- BMC Complement Med Ther. 2024 Apr 25;24(1):174. [Abstract]
- Chem Biol Drug Des. 2021 May;97(5):1089-1099. [Abstract]
- Am J Physiol Endocrinol Metab. 2025 Oct 24. [Abstract]
- mSphere. 2025 Apr 10:e0006125. [Abstract]
- Cell Biol Int. 2021 Jan;45(1):188-197. [Abstract]
- Arch Biochem Biophys. 2021 Nov 15:712:109026. [Abstract]
- Exp Eye Res. 2025 May:254:110328. [Abstract]
- J Cardiovasc Transl Res. 2022 Aug;15(4):740-753. [Abstract]
- Reprod Sci. 2022 Jan;29(1):173-183. [Abstract]
- Graefes Arch Clin Exp Ophthalmol. 2025 Jun;263(6):1585-1596. [Abstract]
- J Dig Dis. 2024 Jul;25(7):453-462. [Abstract]
- Biomed Res Int. 2019 May 16:2019:2821731. [Abstract]
- Folia Histochem Cytobiol. 2025;63(2):53-64. [Abstract]
- Biol Pharm Bull. 2023;46(4):574-585. [Abstract]
- Gen Comp Endocrinol. 2018 Dec 1:269:33-45. [Abstract]
- University of Sao Paulo. 2025 Jul 17.
- SSRN. 2025 Mar 5.
- SSRN. 2025 Jan 13.
- bioRxiv. 2024 September 01.
- bioRxiv. 2024 August 23.
- bioRxiv. 2024 Jan 22.
- Research Square Preprint. 2023 Jul 25.
- Research Square Preprint. 2022 Jul.
- Research Square Preprint. 2022 May.
-
WB
-
WB
-
In Vivo Efficacy Study
-
WB
-
WB
Actividad biológica
IC50: 30 nM (Foxo1)[1]
AS1842856 potently inhibits human Foxo1 transactivation and reduces glucose production through the inhibition of glucose-6 phosphatase and phosphoenolpyruvate carboxykinase mRNA levels in a rat hepatic cell line[1]. After AS1842856 treatment, there is no significant difference in the protein expression of p-FoxO1 and FoxO1 compared with the control group, but the expression of p-Akt is decreased compared with the control group[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 836620-48-5
-
Appearance Solid
-
Peso molecular 347.38
-
Fòrmula C18H22FN3O3
-
Color White to light yellow
-
SMILES
O=C(C1=CN(CC)C2=C(C(N)=C(F)C(NC3CCCCC3)=C2)C1=O)O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (92)
-
Journal Impact Factor
-
Most Recent
-
Cell
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death. [Abstract]2024 Feb 1;187(3):624-641.e23. PMID: 38211590 -
Cell Res
2025 Aug 29. PMID: 40883608 -
Nat Cell Biol
Diet-derived galactose reprograms hepatocytes to prevent T cell exhaustion and elicit antitumour immunity. [Abstract]2025 Aug;27(8):1357-1366. PMID: 40781141 -
Cancer Res
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment. [Abstract]2024 Sep 16;84(18):2985-3003. PMID: 38885318 -
Theranostics
Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis. [Abstract]2021 Jul 25;11(18):8624-8639. PMID: 34522203
AS1842856 purchased from MedChemExpress. Usage Cited in: Theranostics. 2021 Jul 25;11(18):8624-8639. [Abstract]
AS group that received an infusion of FoxO1 inhibitor AS1842856 (AS, 20 mg/kg/day) was studied. Representative Western blot images of LC3, Beclin1, and p62 expressions in the myocardium of five groups of mice were shown.
-
J Adv Res
Panaxatriol exerts anti-senescence effects and alleviates osteoarthritis and cartilage repair fibrosis by targeting UFL1. [Abstract]2025 Aug:74:493-511. PMID: 39442872
AS1842856 purchased from MedChemExpress. Usage Cited in: J Adv Res. 2025 Aug:74:493-511. [Abstract]
Based on the FOXO1 inhibitor (AS1842856) (10 μM; 48 h) and UFL1-KO cells, Western blot was used to detect the influence of FOXO1 on the ability of UFL1 to regulate COL1.
-
Exp Mol Med
TAZ as a novel regulator of oxidative damage in decidualization via Nrf2/ARE/Foxo1 pathway. [Abstract]2021 Sep;53(9):1307-1318. PMID: 34497345 -
Mol Ther
Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness. [Abstract]2026 Jun 2:S1525-0016(26)00470-3. PMID: 42231576 -
Redox Biol
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch. [Abstract]2022 Jun;52:102311. PMID: 35413642
AS1842856 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2022 Jun;52:102311. [Abstract]
The mice were then treated with the FoxO1 inhibitor AS1842856 at a dosage of 100 mg/kg by oral gavage twice daily for two days immediately following each Dox injection. Representative blots and quantitative data of Mfn2 protein levels were shown.
AS1842856 purchased from MedChemExpress. Usage Cited in: Redox Biol. 2022 Jun;52:102311. [Abstract]
The mice were then treated with FoxO1 inhibitor AS1842856 at the dosage of 100 mg/kg by oral gavage twice daily for two days immediately following each Dox injection. Representative mitochondrial images were obtained by transmission electron microscopy.
-
Cell Rep Med
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy. [Abstract]2025 Dec 16;6(12):102513. PMID: 41406940 -
Cell Rep Med
Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis. [Abstract]2025 Sep 25:102371. PMID: 41005298 -
J Exp Med
IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation. [Abstract]2023 Oct 2;220(10):e20221653. PMID: 37466652 -
Cell Mol Biol Lett
2025 Mar 31;30(1):38. PMID: 40165083 -
Mol Biomed
Iron accumulation in hypothalamus promotes age-dependent obesity and metabolic dysfunction of male mice. [Abstract]2025 Oct 2;6(1):75. PMID: 41037185 -
Cell Death Dis
Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells. [Abstract]2023 Aug 8;14(8):508. PMID: 37550282 -
Cell Death Dis
S-nitrosylation of the Peroxiredoxin-2 promotes S-nitrosoglutathione-mediated lung cancer cells apoptosis via AMPK-SIRT1 pathway. [Abstract]2019 May; 10(5): 329. PMID: 30988280 -
Sci China Life Sci
2022 Dec;65(12):2505-2516. PMID: 35661964 -
Proc Natl Acad Sci U S A
2021 Nov 16;118(46):e2105950118. PMID: 34772808 -
Acta Pharmacol Sin
2024 Apr;45(4):714-727. PMID: 38191912 -
Phytomedicine
Targeting tumor metabolism: The dual attack of emodin on glycolysis and oxidative phosphorylation in esophageal squamous cell carcinoma. [Abstract]2025 Jun 8:144:156958. PMID: 40513325 -
Apoptosis
Ambra1 regulates apoptosis and chemosensitivity in breast cancer cells through the Akt-FoxO1-Bim pathway. [Abstract]2022 Jun;27(5-6):329-341. PMID: 35257265 -
J Orthop Translat
FOXO1-mTOR pathway in vascular pericyte regulates the formation of type H vessels to control bone metabolism. [Abstract]2024 Sep 17:49:246-263. PMID: 39524152 -
Redox Rep
FOXO1-NMNAT3 axis dysregulation promotes doxorubicin cardiotoxicity: NAD+ replenishment as a redox-targeted antioxidant therapy. [Abstract]2025 Dec;30(1):2565033. PMID: 41021886 -
Cell Mol Gastroenterol Hepatol
Sorafenib Promotes Treg Cell Differentiation To Compromise Its Efficacy via VEGFR/AKT/Foxo1 Signaling in Hepatocellular Carcinoma. [Abstract]2024 Dec 30:101454. PMID: 39743020 -
Chin Med J (Engl)
Chidamide triggers pyroptosis in T-cell lymphoblastic lymphoma/leukemia via the FOXO1/GSDME axis. [Abstract]2025 May 20;138(10):1213-1224. PMID: 39445538 -
Stem Cell Res Ther
Human adipose and synovial-derived MSCs synergistically attenuate osteoarthritis by promoting chondrocyte autophagy through FoxO1 signaling. [Abstract]2024 Aug 15;15(1):261. PMID: 39148121 -
Aging Cell
Identification of AS1842856 as a novel small-molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis. [Abstract]2024 Sep 17:e14336. PMID: 39287420 -
Aging Cell
Lipoteichoic acid restrains macrophage senescence via β-catenin/FOXO1/REDD1 pathway in age-related osteoporosis. [Abstract]2024 Mar;23(3):e14072. PMID: 38126583 -
Cell Death Discov
2025 Nov 7;11(1):509. PMID: 41203613 -
Cell Rep
2025 Sep 29;44(10):116361. PMID: 41026602 -
Cell Rep
FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity. [Abstract]2021 Apr 6;35(1):108935. PMID: 33826891 -
Antioxidants (Basel)
Glucuronolactone Restores the Intestinal Barrier and Redox Balance Partly Through the Nrf2/Akt/FOXO1 Pathway to Alleviate Weaning Stress-Induced Intestinal Dysfunction in Piglets. [Abstract]2025 Mar 18;14(3):352. PMID: 40227425 -
Mol Metab
2021 Jul:49:101187. PMID: 33577983 -
J Agric Food Chem
Rosmarinic Acid Ameliorates Type 2 Diabetic Osteoporosis by Reducing NLRP3 Expression and Alleviating Osteoblast Pyroptosis via the FOXO1/TXNIP Signaling Pathway. [Abstract]2025 Jul 2;73(26):16557-16572. PMID: 40552618 -
Diabetes Obes Metab
FOXO1 reduces STAT3 activation and causes impaired mitochondrial quality control in diabetic cardiomyopathy. [Abstract]2024 Feb;26(2):732-744. PMID: 37961034 -
Cell Prolif
Targeting Egfr-Mediated Cell Proliferation and Lipid Metabolism Separation Effectively Accelerate Liver Regeneration. [Abstract]2026 Apr 22:e70214. PMID: 42019507 -
Biochem Pharmacol
Eicosatrienoic acid inhibits estradiol synthesis through the CD36/FOXO1/CYP19A1 signaling pathway to improve PCOS in mice. [Abstract]2024 Sep 3:116517. PMID: 39236935 -
Food Funct
Genistein exhibits therapeutic potential for PCOS mice via the ER-Nrf2-Foxo1-ROS pathway. [Abstract]2021 Sep 20;12(18):8800-8811. PMID: 34374402 -
Drug Des Devel Ther
FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription. [Abstract]2025 Mar 5:19:1543-1560. PMID: 40061815 -
CNS Neurosci Ther
AS1842856 Reduces β-Amyloid Burden via Inhibiting PLA2G4A-Mediated Lysosomal Dysfunction in APP/PS1 Mice. [Abstract]2026 Apr;32(4):e70910. PMID: 42047940 -
CNS Neurosci Ther
Alleviation of Microglia Mediating Hippocampal Neuron Impairments and Depression-Related Behaviors by Urolithin B via the SIRT1-FOXO1 Pathway. [Abstract]2025 Apr;31(4):e70379. PMID: 40237232 -
Immunology
The Hippo kinase MST1 negatively regulates the differentiation of follicular helper T cells. [Abstract]2023 Mar;168(3):511-525. PMID: 36210514 -
PLoS Pathog
2025 Apr 1;21(4):e1012524. PMID: 40168429 -
PLoS Pathog
Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. [Abstract]2023 Aug 18;19(8):e1011581. PMID: 37594999 -
Int J Mol Sci
Insulin-like Growth Factor 1 Promotes Cell Proliferation by Downregulation of G-Protein-Coupled Receptor 17 Expression via PI3K/Akt/FoxO1 Signaling in SK-N-SH Cells. [Abstract]2022 Jan 28;23(3):1513. PMID: 35163437 -
Int J Mol Sci
The Role of the FOXO1/β2-AR/p-NF-κB p65 Pathway in the Development of Endometrial Stromal Cells in Pregnant Mice under Restraint Stress. [Abstract]2021 Feb 2;22(3):1478. PMID: 33540675 -
J Nutr Biochem
1,25-Dihydroxyvitamin D attenuates diabetic cardiac autophagy and damage by vitamin D receptor-mediated suppression of FoxO1 translocation. [Abstract]2020 Jun;80:108380. PMID: 32299030 -
Int Immunopharmacol
DPEP1 mediates regulation of mitochondrial quality control via FOXO1/ALDH1L2 axis to attenuate ferroptosis in pulmonary endothelial cells to alleviate sepsis-associated acute lung injury. [Abstract]2025 Dec 19:170:116049. PMID: 41421227 -
Int Immunopharmacol
SIRT6 knockdown alleviates keratinocyte hyperproliferation and inflammation in psoriasis via modulating acetylation of FOXO1. [Abstract]2024 Dec 28:146:113932. PMID: 39733643 -
Biosci Rep
The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. [Abstract]2019 May 10;39(5):BSR20190112. PMID: 30967498 -
Toxicology
Prenatal dexamethasone exposure caused fetal rats liver dysplasia by inhibiting autophagy-mediated cell proliferation. [Abstract]2021 Feb 15:449:152664. PMID: 33359579 -
Front Cell Dev Biol
2021 Aug 26;9:666422. PMID: 34513822 -
J Cell Mol Med
FKBP5 Regulates Osteogenesis of Human iPSC-Derived Mesenchymal Stem Cells via FKBP5-AKT-FOXO1 Pathway. [Abstract]2025 Nov;29(21):e70849. PMID: 41170704 -
Mol Nutr Food Res
Punicalagin Ameliorates Diabetic Liver Injury by Inhibiting Pyroptosis and Promoting Autophagy via Modulation of the FoxO1/TXNIP Signaling Pathway. [Abstract]2024 Jun 7:e2300912. PMID: 38847553 -
FASEB J
LDHA deficiency inhibits trophoblast proliferation via the PI3K/AKT/FOXO1/CyclinD1 signaling pathway in unexplained recurrent spontaneous abortion. [Abstract]2023 Feb;37(2):e22744. PMID: 36583693 -
FASEB J
Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through β-catenin/Foxo1/TLR4 signaling. [Abstract]2022 May;36(5):e22316. PMID: 35429042 -
FASEB J
MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia. [Abstract]2020 Oct;34(10):13762-13775. PMID: 32808351 -
FEBS J
Knockdown of SGK1 alleviates the IL-1β-induced chondrocyte anabolic and catabolic imbalance by activating FoxO1-mediated autophagy in human chondrocytes. [Abstract]2020 Jan;287(1):94-107. PMID: 31330080 -
iScience
2023 Jul 11;26(8):107293. PMID: 37520709 -
J Integr Med
Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. [Abstract]2021 Nov;19(6):545-554. PMID: 34686466 -
Sci Rep
Mild hypothermia attenuates hepatic ischemia-reperfusion injury by regulating FoxO1/PPARα pathway. [Abstract]2025 Aug 6;15(1):28800. PMID: 40770269 -
J Biol Chem
2024 Apr;300(4):107209. PMID: 38519029 -
J Biol Chem
An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice. [Abstract]2021 Jul;297(1):100846. PMID: 34058194 -
J Biol Chem
Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1. [Abstract]2020 Mar 27;295(13):4265-4276. PMID: 32075913 -
Int Dent J
Forkhead Box O1 Promotes Osteogenesis of Periodontal Ligament Stem Cells Via Glycolysis-Related Metabolic Reprogramming. [Abstract]2026 Jun 5;76(4):109664. PMID: 42247869 -
ACS Pharmacol Transl Sci
Opposing Interplay between Nuclear Factor Erythroid 2-Related Factor 2 and Forkhead BoxO 1/3 is Responsible for Sepantronium Bromide's Poor Efficacy and Resistance in Cancer cells: Opportunity for Combination Therapy in Triple Negative Breast Cancer. [Abstract]2024 Apr 29;7(5):1237-1251. PMID: 38751638 -
Mol Cell Biochem
CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling. [Abstract]2023 Jul;478(7):1561-1571. PMID: 36434144
AS1842856 purchased from MedChemExpress. Usage Cited in: Mol Cell Biochem. 2023 Jul;478(7):1561-1571. [Abstract]
AS1842856 (1 μM; 48 h) reverses CEP55 downregulation-mediated inhibition of PCNA and CDK2 levels and elevation of cl-caspase-3 expression in Ishikawa and RL95-2 cells.
-
Eur J Med Res
Integrated transcriptomic analysis and experimental validation identify ACADL as a mitochondrial tumor suppressor via the FOXO3a/PUMA axis in lung adenocarcinoma. [Abstract]2026 Jan 5;31(1):202. PMID: 41491963 -
BMC Complement Med Ther
2024 Apr 25;24(1):174. PMID: 38664638 -
Chem Biol Drug Des
2021 May;97(5):1089-1099. PMID: 33560565 -
Am J Physiol Endocrinol Metab
Control of Hepatic Gluconeogenesis in Mice Fed a High Protein Diet: A Transcriptional Shift from CREB to FoxO1. [Abstract]2025 Oct 24. PMID: 41134648 -
mSphere
Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. [Abstract]2025 Apr 10:e0006125. PMID: 40207917 -
Cell Biol Int
Bone marrow mesenchymal stem cells inhibit cardiac hypertrophy by enhancing FoxO1 transcription. [Abstract]2021 Jan;45(1):188-197. PMID: 33049085 -
Arch Biochem Biophys
SMC4 knockdown inhibits malignant biological behaviors of endometrial cancer cells by regulation of FoxO1 activity. [Abstract]2021 Nov 15:712:109026. PMID: 34506757 -
Exp Eye Res
SIRT3 mitigates dry eye disease through the activation of autophagy by deacetylation of FOXO1. [Abstract]2025 May:254:110328. PMID: 40064414 -
J Cardiovasc Transl Res
SIRT6 Protects Against Myocardial Ischemia-Reperfusion Injury by Attenuating Aging-Related CHMP2B Accumulation. [Abstract]2022 Aug;15(4):740-753. PMID: 35235147 -
Reprod Sci
FoxO1 Regulates Neuropeptide Y and Pro-opiomelanocortin in the Hypothalamus of Rat Offspring Small for Gestational Age. [Abstract]2022 Jan;29(1):173-183. PMID: 34767244 -
Graefes Arch Clin Exp Ophthalmol
2025 Jun;263(6):1585-1596. PMID: 39878886 -
J Dig Dis
Inhibition of FoxO1 ameliorates hepatic steatosis and hepatitis in nonalcoholic steatohepatitis mice through regulation of gut microbiota. [Abstract]2024 Jul;25(7):453-462. PMID: 39211938 -
Biomed Res Int
MiR-21-3p Plays a Crucial Role in Metabolism Alteration of Renal Tubular Epithelial Cells during Sepsis Associated Acute Kidney Injury via AKT/CDK2-FOXO1 Pathway. [Abstract]2019 May 16:2019:2821731. PMID: 31223614 -
Folia Histochem Cytobiol
Upregulation of SIRT1 ameliorates apoptosis of rat nucleus pulposus cells under oxidative stress through FoxO1/β-catenin pathway. [Abstract]2025;63(2):53-64. PMID: 40421819 -
Biol Pharm Bull
Anticancer Activity of Methyl Protodioscin against Prostate Cancer by Modulation of Cholesterol-Associated MAPK Signaling Pathway via FOXO1 Induction. [Abstract]2023;46(4):574-585. PMID: 37005301 -
Gen Comp Endocrinol
Different roles of insulin receptor a and b in maintaining blood glucose homeostasis in zebrafish. [Abstract]2018 Dec 1:269:33-45. PMID: 30102881 -
-
-
-
-
-
-
-
-
Solvente y solubilidad
DMSO : 5 mg/mL (14.39 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 1 mg/mL (2.88 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 1 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1 mg/mL (2.88 mM); Clear solution
This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 6% HP-β-CD in Saline
Solubility: 10 mg/mL (28.79 mM); Suspension solution; Need ultrasonic
Add each solvent one by one: 0.5% CMC/saline water
Solubility: 2 mg/mL (5.76 mM); Suspended solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocolo
Rat hepatoma Fao cells are cultured in DMEM with 5.5 mM glucose and 10% FBS. Glucose production rate is measured using glucose CII-test reagent. In brief, after 18 h of treatment with AS1842856 at the indicated concentrations, the cells are ished three times with PBS. The cells are then incubated for 3 h at 37°C in 5% CO2 in a glucose production buffer (glucose-free DMEM, pH 7.4, containing 20 mM sodium pyruvate, without phenol red)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
AS1842856 is dissolved in 6% cyclodextrin for oral administration. Pyruvate or glucose tolerance tests are performed in male mice aged 7 to 9 weeks. Mice are orally administered either AS1842856 dissolved in 6% cyclodextrin or vehicle (6% cyclodextrin only) at three time points (8 AM, 6 PM, and 8 AM on the second day). Food is removed after initial dosing and withheld throughout the study (26-h fasting)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Pureza y Documentación
-
Ficha de datos (278 KB)
-
SDS (597 KB)
- English - EN (597 KB)
- Français - FR (597 KB)
- Deutsch - DE (597 KB)
- Norwegian - NO (597 KB)
- Español - ES (597 KB)
- Swedish - SV (597 KB)
- Italian - IT (597 KB)
- Korean - KR (597 KB)
- Portuguese - PT (597 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Nagashima T, et al. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol. 2010 Nov;78(5):961-70. [Content Brief]
[2]. He J, et al. The resistant effect of SIRT1 in oxidative stress-induced senescence of rat nucleus pulposus cell is regulated by Akt-FoxO1 pathway. Biosci Rep. 2019 May 10;39(5). pii: BSR20190112. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8787 mL | 14.3935 mL | 28.7869 mL | 71.9673 mL |
| 5 mM | 0.5757 mL | 2.8787 mL | 5.7574 mL | 14.3935 mL | |
| 10 mM | 0.2879 mL | 1.4393 mL | 2.8787 mL | 7.1967 mL |